These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21610601)

  • 1. Hydroxyethyl starch-induced bleeding after cardiac surgery.
    Haynes GR
    Crit Care Med; 2011 May; 39(5):1239-40; author reply 1240-1. PubMed ID: 21610601
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
    Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding that won't stop.
    Edmunds LH; Colman RW
    Ann Thorac Surg; 2008 Apr; 85(4):1153-4. PubMed ID: 18355487
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant activated factor VII and cardiac surgery.
    De Santis V; Vitale D; Tritapepe L; Pietropaoli P
    Ann Thorac Surg; 2008 Dec; 86(6):2025; author reply 2025. PubMed ID: 19022049
    [No Abstract]   [Full Text] [Related]  

  • 8. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery.
    Niemi TT; Suojaranta-Ylinen RT; Kukkonen SI; Kuitunen AH
    Anesth Analg; 2006 Apr; 102(4):998-1006. PubMed ID: 16551888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood conservation in cardiac surgery: let's get restrictive.
    Varghese R; Myers ML
    Semin Thorac Cardiovasc Surg; 2010; 22(2):121-6. PubMed ID: 21092889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery.
    Emmert MY; Salzberg SP; Theusinger OM; Felix C; Plass A; Hoerstrup SP; Falk V; Gruenenfelder J
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):183-8. PubMed ID: 20829389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of recombinant activated factor VII in major thoracic operations.
    Alavi AA; Jalali SM; Rasouli MR; Eghtesadi-Araghi P
    Arch Surg; 2008 Oct; 143(10):1021; author reply 1021. PubMed ID: 18936387
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed sternal closure: an effective procedure for life-saving in open-heart surgery.
    Yasa H; Lafçi B; Yilik L; Bademci M; Sahin A; Kestelli M; Yeşil M; Gürbüz A
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):163-7. PubMed ID: 20382617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogenic blood transfusion in cardiac surgery.
    Crescenzi G; Torracca L; Capestro F; Matteucci ML; Rossi M
    J Card Surg; 2012 Sep; 27(5):594-9. PubMed ID: 22978836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative blood loss and transfusion associated with use of Hextend in cardiac surgery patients at a blood conservation center.
    Moskowitz DM; Shander A; Javidroozi M; Klein JJ; Perelman SI; Nemeth J; Ergin MA
    Transfusion; 2008 Apr; 48(4):768-75. PubMed ID: 18248568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses.
    Pompei E; Tursi V; Guzzi G; Vendramin I; Ius F; Muzzi R; Auci E; Badano LP; Livi U
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):170-4. PubMed ID: 19934767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-operative surgery in pediatric patients.
    Delius RE; Walters HL
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2003; 6():108-15. PubMed ID: 12740777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peroperative blood autotransfusion in heart surgery].
    Gherli T; Porcu A; Padua G; Marongiu G; Mura L; Sale MA; Bacciu PP
    Minerva Cardioangiol; 1991 Sep; 39(9):329-31. PubMed ID: 1787891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding complications and blood product utilization with left ventricular assist device implantation.
    Schaffer JM; Arnaoutakis GJ; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
    Ann Thorac Surg; 2011 Mar; 91(3):740-7; discussion 747-9. PubMed ID: 21352991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
    Israelian LA; Lubnin AIu
    Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.